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School of Agricultural Science, Kobe University, Kobe 657-8501, Japan; cDepartment of Pharmacology, Miyazaki 
Medical College, University of Miyazaki, Miyazaki, 889-1692 Japan; dDepartment of Biomolecular Science, Graduate 
School of Life Science, Tohoku University, Sendai, 980-8578 Japan; eDepartment of Pharmacology, Graduate School of 
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ABSTRACT Using specific inhibitors, kinase-negative mutants, and small interfering RNA 
against protein kinase Cα (PKCα) or PKCβI, we find that PKCβI positively regulates degranula-
tion in rat basophilic leukemia–2H3 cells, whereas PKCα negatively regulates degranulation. 
Mass spectrometric and mutagenic analyses reveal that PKCα phosphorylates cofilin at Ser-23 
and/or Ser-24 during degranulation. Overexpression of a nonphosphorylatable form 
(S23,24A), but not that of a mutant-mimicking phosphorylated form (S23,24E), increases de-
granulation. Furthermore, the S23,24A mutant binds to F-actin and retains its depolymerizing 
and/or cleavage activity; conversely, the S23,24E mutant is unable to sever actin filaments, 
resulting in F-actin polymerization. In addition, the S23,24E mutant preferentially binds to the 
14-3-3ζ protein. Fluorescence-activated cell sorting analysis with fluorescein isothiocyanate–
phalloidin and simultaneous observation of degranulation, PKC translocation, and actin po-
lymerization reveals that during degranulation, actin polymerization is dependent on PKCα 
activity. These results indicate that a novel PKCα-mediated phosphorylation event regulates 
cofilin by inhibiting its ability to depolymerize F-actin and bind to 14-3-3ζ, thereby promoting 
F-actin polymerization, which is necessary for cessation of degranulation.
INTRODUCTION
Histamine was identified in the early 1900s as a mediator of biologi-
cal events, and drugs targeting its receptors have been in clinical 
use for more than 60 years. Histamine exerts a range of effects on 
many physiological and pathological processes, and new roles are 
still being elucidated. The best-characterized property of histamine 
is its role in inflammation, during which it is released from both mast 
cells and basophils (Galli, 2000).
Connective tissue mast cells have been used for many years to 
investigate the mechanisms of histamine release because they are 
easy to obtain, particularly from the peritoneal cavity. Conversely, 
mucosal mast cells (MMCs) and basophils are more difficult to iso-
late and have therefore been disregarded (Befus et al., 1982). How-
ever, the rat basophilic leukemia (RBL)-2H3 mast cell line has been 
developed and used in many studies (Barsumian et al., 1981) be-
cause the cells exhibit some of the typical characteristics of both 
MMCs and basophils (Siraganian et al., 1982).
Through experiments using RBL-2H3 cells, the signaling path-
ways involved in histamine release have been revealed. Antigen-
driven cross-linking of cell-surface FcεRI receptors initiates a sig-
naling cascade via the engagement of protein tyrosine kinases of 
the Src and Syk families (Turner and Kinet, 1999). Lyn, a Src family 
kinase, phosphorylates the immunoreceptor tyrosine-based 
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RESULTS
Distinct roles of PKCα and PKCβI in degranulation
The membrane translocation of PKC is a good marker for its activa-
tion (Kraft et al., 1982; Sakai et al., 1997; Shirai et al., 1998), and 
RBL-2H3 cells possess several PKC isoforms, including the PKCα, 
βI, ε, δ, and ζ isoforms (unpublished data). To determine which 
PKC isoform(s) are activated during degranulation, we monitored 
the translocation of green fluorescent protein (GFP)–fused PKCα, 
βI, ε, δ, and ζ. Stimulation with 1 μM ionomycin induced significant 
translocation of PKCα and βI, as well as a slight but significant 
degree of PKCε translocation to the plasma membrane (Figure 1, 
A and C). In contrast, no translocation of PKCδ and ζ was detected 
(Figure 1, A and C). The application of dinitrophenyl–bovine serum 
albumin (DNP-BSA) to immunoglobulin E (IgE)–treated cells 
(so-called antigen stimulation) evoked membrane translocation of 
all PKCs, except for the ζ isoform (Figure 1, B and D); however, 
statistical analysis indicated that translocation of PKCδ was insig-
nificant. These results suggest that PKCα, βI , and ε are involved in 
the degranulation of RBL-2H3 cells in response to both ionomycin 
and antigen stimulation. In addition, a selective inhibitor of cPKCs, 
Gö6976, inhibited both ionomycin- and antigen-induced degranu-
lation in a dose-dependent manner (Figure 1E); this result confirms 
the involvement of PKCα and/or βI in the degranulation of RBL-
2H3 cells.
To further examine the cPKC isoform(s) involved in the degranu-
lation of RBL-2H3 cells, we observed the movement of PKCs during 
degranulation. To visualize the granules, we used a DsRed-fused 
signal peptide of β-hexosaminidase (DsRed-signal peptide), which 
is included in the same granules and released with histamine. The 
DsRed-signal peptide colocalized with histamine granules (Figure 
2A) and disappeared upon ionomycin-induced (Figure 2B) or anti-
gen-induced degranulation (Supplemental Figure S1, A and B), sug-
gesting that this peptide was effective for visualizing granules dur-
ing the degranulation process. Careful observation of the GFP-PKCs 
and granules revealed that after membrane translocation, PKCα ac-
cumulated on the membrane at exocytotic sites just after ionomy-
cin-induced secretion (Figure 2B, left). In contrast, PKCβI accumula-
tion around the granules was observed just before secretion (Figure 
2B, right). Similar results were obtained upon antigen stimulation 
(Supplemental Figure S1, A and B), suggesting that PKCα and PKCβI 
have temporally different individual roles during degranulation.
To determine the individual roles of PKCα and βI in degranula-
tion, we examined the effects of selective PKC inhibitors and PKCα 
or βI overexpression. Overexpression of the PKCα kinase-negative 
(KN) mutant enhanced ionomycin-induced degranulation, but over-
expression of wild-type (WT) PKCα did not significantly alter de-
granulation (Figure 2C). In contrast, overexpression of GFP-PKCβI 
WT increased ionomycin-induced degranulation, whereas overex-
pression of GFP-PKCβI KN suppressed degranulation (Figure 1C). 
Similar results were obtained upon antigen stimulation (Supple-
mental Figure S1C). Moreover, azelastine, a PKCα inhibitor, pro-
moted ionomycin-induced degranulation in a dose-dependent 
manner (Figure 2D). In contrast, LY333531, a specific inhibitor of 
PKCβI, prevented degranulation (Figure 2D). Similar effects were 
observed in the case of antigen stimulation (Supplemental Figure 
S1D). Finally, the distinct roles of PKCα and βI in degranulation 
were confirmed via small interfering RNA (siRNA)–mediated knock-
down. After transfection into RBL-2H3 cells, siRNA against either 
PKCα or βI successfully reduced PKCα or βI expression, respec-
tively (Figure 2E). Treatment of siRNA against PKCα enhanced de-
granulation, but PKCβI knockdown inhibited ionomycin-induced 
degranulation (Figure 2E). Similar results were obtained in the case 
activation motifs present in the FcεRIβ and γ subunits (Pribluda 
et al., 1994). This phosphorylation leads to the recruitment and 
subsequent activation of Syk kinase, which phosphorylates sev-
eral downstream signaling molecules, including the linker for ac-
tivation of T-cells (LAT; Saitoh et al., 2000). Phosphorylated LAT 
recruits a number of signaling molecules containing Src homol-
ogy 2 domains, such as the adaptor protein Grb2 and phospholi-
pase Cγ (PLCγ; Kinet, 1999). Activated PLCγ hydrolyzes phos-
phatidylinositol-4,5-bisphosphate, resulting in the production of 
inositol-1,4,5-triphosphate (IP3) and diacylglycerol (DAG). DAG 
activates protein kinase C (PKC), and IP3 mediates the release of 
intracellular calcium from the endoplasmic reticulum, which is re-
quired to open calcium channels in the plasma membrane. In-
creases in calcium and PKC activation are required for mast cell 
degranulation (Ozawa et al. 1993b). The calcium ionophores 
A23185 and ionomycin can induce mast cell degranulation with-
out additional stimuli (Lo et al., 1987) because the pharmacologi-
cal agents bypass FcεRI-proximal signaling events and directly 
stimulate cells by mobilizing free calcium ions and activating PKC 
(Hanson and Ziegler, 2002).
The FcεRI-mediated increase in cytoplasmic calcium triggers de-
granulation via reorganization of actin filaments and microtubules 
(Smith et al., 2003; Blank and Rivera, 2004). Studies with actin-spe-
cific drugs have established that cortical actin filaments function as 
a barrier to prevent granules from reaching the plasma membrane 
for exocytosis. Calcium-induced cortical F-actin disassembly is par-
ticularly important for secretory cells (Burgoyne and Cheek, 1985). 
Thus actin remodeling is intimately linked to the extensively regu-
lated degranulation process.
PKC, the other essential factor for degranulation, consists of 10 
isoforms that are characterized according to their molecular struc-
ture and activation requirements. All PKCs require phosphatidylser-
ine (PS) for activation. The conventional PKCs (cPKC), including α, 
βI, βII, and γ, require both DAG and calcium ions, whereas novel 
PKCs (δ, ε, η, and θ) depend only on DAG. The atypical PKCs (ζ and 
ι/λ) are activated by PS but not by DAG or calcium (Nishizuka, 1988, 
1992). RBL-2H3 cells contain PKCα, βI, ε, δ, and ζ, and different 
roles in degranulation have been reported for the particular PKC 
isoforms. For example, PKCα and ε have been shown to inhibit 
PLCγ, which suppresses degranulation (Ozawa et al., 1993a). An 
analysis of bone marrow–derived mast cells (BMMCs) from PKCβ-
deficient mice revealed the positive function of PKCβ (Nechushtan 
et al., 2000); in contrast, PKCα has been reported to perform a neg-
ative function (Ozawa et al., 1993a). Conversely, a positive role for 
PKCα in degranulation has been suggested (Powner et al., 2002), 
and PKCδ has been shown to negatively regulate degranulation in 
PKCδ-deficient BMMCs (Leitges et al., 2002). These controversial 
reports demonstrate the need to determine individual PKC func-
tions in degranulation. In addition, the molecules downstream of 
PKCs during degranulation have not been reported.
Therefore we examined the distinct functions of PKCs and iden-
tified PKC substrates during degranulation in RBL-2H3 cells. Our 
results revealed a positive role for PKCβI and a negative role for 
PKCα in degranulation. Furthermore, we identified the actin-remod-
eling protein cofilin as a substrate of PKCα. Specifically, PKCα phos-
phorylated cofilin at Ser-23 and/or Ser-24 upon stimulation with 
FcεRI or ionomycin. Phosphorylation of cofilin inhibited its actin-
depolymerizing and actin-severing activities, suppressing excess 
histamine release from RBL-2H3 cells. The PKCα phosphorylation 
site is conserved in mammals and birds, suggesting that the well-
controlled termination mechanism developed in higher animals for 
the rapid termination of histamine release.
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Identification of PKC substrates 
during degranulation
To identify the substrate(s) of PKCα and/or 
βI in the degranulation process, we treated 
32P-loaded RBL-2H3 cells with ionomycin, 
and analyzed phosphoproteins via two-di-
mensional electrophoresis and autoradiog-
raphy. Stimulation with ionomycin induced 
phosphorylation of a protein of ∼19 kDa, but 
this phosphorylation was abolished by treat-
ment with Gö6976 (Figure 3A), indicating 
that this protein was phosphorylated by 
PKCα and/or βI during degranulation. Mass 
spectrometric analysis of the two-dimen-
sional gel spot revealed that the protein was 
cofilin-1 (cofilin). To confirm that cofilin was 
indeed phosphorylated by cPKC during de-
granulation of RBL-2H3 cells, we loaded 
cells expressing FLAG-tagged cofilin (cofi-
lin-FLAG) with [γ-32P] and stimulated them 
with ionomycin or antigen; we then per-
formed immunoprecipitation and autora-
diography. Phosphorylation of cofilin-FLAG 
was observed at 5 min after ionomycin stim-
ulation, and Gö6976 significantly inhibited 
this phosphorylation (Figure 3B, left). A simi-
lar result was obtained with antigen stimula-
tion (Figure 3B, right), confirming that cofilin 
was phosphorylated in a cPKC-dependent 
manner during degranulation.
Cofilin is an actin-binding protein. Al-
though it shows complex behavior toward 
actin, cofilin phosphorylation generally pro-
motes actin polymerization (Bamburg, 
1999), which has an inhibitory effect on de-
granulation (Frigeri and Apgar, 1999). In 
light of these reports, we hypothesized that 
PKCα phosphorylates cofilin. Therefore the 
effects of a PKCα inhibitor on the in vivo 
phosphorylation of cofilin were examined. 
As expected, 10 μM azelastine abolished 
both ionomycin- and antigen-induced cofi-
lin phosphorylation (Figure 3C). In addition, 
the same concentration of azelastine inhib-
ited ionomycin-induced activation of PKCα 
but not that of PKCβI (Supplemental Figure 
S2B), confirming the specificity of azelastine. 
The involvement of PKCα in cofilin phos-
phorylation was also confirmed by PKCα 
siRNA treatment (Figure 3D), suggesting 
that cofilin is a substrate of PKCα.
Phosphorylation of cofilin at Ser-3 in the 
actin-binding domain by the Lin-11/Isl-1/
Mec-3 (LIM) and testicular protein (TES) 
kinases results in cofilin inactivation 
(Bamburg, 1999). However, Ser-3 is not a 
consensus PKC phosphorylation site. In ad-
dition, cofilin was directly phosphorylated by PKCα in vitro, but a 
substitution of Ser-3 to Ala (S3A) did not alter the phosphorylation 
level (Supplemental Figure S3A), indicating that Ser-3 is not the 
phosphorylation site(s) by PKCα. To identify the residue(s) phos-
phorylated by PKCα, we performed an in vitro phosphorylation 
of antigen stimulation (Supplemental Figure S1E). More important, 
overexpression of GFP-PKCα or PKCβI rescued the respective ef-
fect of siRNA of PKCα or PKCβI (Figure 2E). These results clearly 
indicate that PKCβI plays a stimulatory role in degranulation, 
whereas PKCα inhibits the process.
FIGURE 1: The translocation of PKCs during degranulation. Translocation of GFP-PKCs in 
RBL-2H3 cells induced by ionomycin (A) or antigen (B). RBL-2H3 cells overexpressing GFP-
tagged PKCα, βI, δ, ε, or ζ were stimulated with 1 μM ionomycin or 50 ng/ml DNP-BSA 
(antigen). The translocation of GFP-PKCs was monitored using confocal microscopy. Bars, 10 
μm. (C, D) Statistical analysis of membrane translocation. The average percentage of the 
membrane fluorescence of total fluorescence is represented as the relative membrane 
fluorescence with SD. Open and closed columns show the results before and after ionomycin (C) 
or DNP-BSA (D) stimulation, respectively (**p < 0.1, *p < 0.05). (E) The effect of the cPKC 
inhibitor Gö6976 on antigen- or ionomycin-induced degranulation. RBL-2H3 cells were 
incubated for 15 min with different concentrations of Gö6976 and then stimulated with either 50 
ng/ml DNP-BSA or 1 μM ionomycin for 15 min. The percentage of β-hexosaminidase release is 
plotted.
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assay with purified PKCα and maltose-bind-
ing protein (MBP)–cofilin in tandem with 
mass spectrometric analysis. Comparing 
the mass spectra in the absence and pres-
ence of ATP showed that at least one serine 
was phosphorylated in the peptide frag-
ment, VFNDMKVRKSSTPEEVKK, which cor-
responds to amino acids 14–31 of cofilin 
(Figure 4A). This peptide contains two ser-
ines, Ser-23 and Ser-24, which are present 
in the consensus phosphorylation sequence 
recognized by PKC. To examine whether 
these serines are phosphorylated by PKCα, 
we performed an in vitro kinase assay with 
cofilin mutants. PKCα phosphorylated wild-
type MBP-cofilin (Figure 4B), confirming 
that PKCα directly phosphorylates recombi-
nant cofilin in vitro. However, when 24 
amino acids, including Ser-23 and Ser-24, 
were deleted from the N-terminus (Nd) or 
when both Ser-23 and Ser-24 were con-
verted to alanines (S23,24A), phosphoryla-
tion by PKCα was nearly eliminated (Figure 
4B). In addition, point mutations of Ser-23 
(S23A) or Ser-24 (S24A) substantially attenu-
ated cofilin phosphorylation (Figure 4B); 
however, phosphorylation was not com-
pletely abolished, suggesting that PKCα 
phosphorylates cofilin at both Ser-23 and 
Ser-24 in vitro. Of importance, an in vivo ki-
nase assay proved that phosphorylation of 
Ser-23 and Ser-24 in cofilin occurred during 
degranulation in RBL-2H3 cells (Figure 4, C 
and D). Ionomycin- and antigen-induced 
phosphorylation of cofilin was markedly re-
duced by the S23,24A substitution. In con-
trast, the S3A mutant, in which Ser-3 (a 
phosphorylation site by LIMK) was con-
verted to alanine, exhibited an insignificant 
reduction in phosphorylation during the de-
granulation process (Figure 4, C and D). 
Phosphorylation of cofilin at Ser-23 and 
Ser-24 during degranulation was also con-
firmed in mouse BMMCs (Figure 4E 
and Supplemental Figure S3B). These 
results indicate that Ser-23 and Ser-24 of 
cofilin are phosphorylated by PKCα during 
degranulation.
Function of novel cofilin 
phosphorylation during degranulation
To further examine how the phosphoryla-
tion of cofilin at Ser-23 and Ser-24 influ-
ences degranulation, we used two cofilin 
mutants—S23,24A and S23,24E, the latter 
of which mimics phosphorylation by substi-
tuting glutamic acid residues for Ser-23 
and Ser-24. After we established cell lines 
that stably expressed DsRed-tagged WT 
cofilin or its mutant derivatives, immunob-
lotting analyses revealed that the expres-
sion of DsRed-cofilin and its mutants was 
FIGURE 2: The distinct roles of PKCα and PKCβI in ionomycin-induced degranulation. (A) The 
colocalization of signal peptide-DsRed2 and histamine in RBL-2H3 cells. RBL-2H3 cells transfected 
with signal peptide-DsRed2 were fixed and stained with anti-histamine and Alexa Fluor 
488-conjugated secondary antibodies. Bar, 10 μm. (B) Representative images of ionomycin-induced 
degranulation and the translocation of GFP-tagged PKCα and βI. RBL-2H3 cells were cotransfected 
with the DsRed-fused signal peptide of β-hexosaminidase and GFP-PKCα (left) or βI (right). After 
24 h, the cells were treated with 1 μM ionomycin and monitored using confocal microscopy. White 
arrows indicate secreting granules. Bars, 10 μm. (C) Effect of overexpression of wild-type (WT) or 
kinase-negative (KN) forms of PKCα (left) and PKCβI (right). RBL-2H3 cells were infected with 
adenovirus encoding GFP-tagged WT or KN PKCα and with those of WT or KN PKCβI . The cells 
were stimulated with 1 μM ionomycin for 15 min, and the percentage of β-hexosaminidase release 
was plotted. The actual release corresponding to percentage of total β-hexosaminidase from 
control cells was 34 ± 2%. (D) Effect of specific inhibitors for PKCα and βI. RBL-2H3 cells were 
pretreated with azelastine or LY333531 for 15 min and stimulated with 1 μM ionomycin in the 
presence of the inhibitor. Data analysis was performed as described in C. (E) Effect of siRNA PKCα 
or βI on degranulation. RBL-2H3 cells were transfected with siRNA specific for PKCα or βI, and 
then GFP-PKCα or βI was overexpressed in some of them. Lysates from the siRNA-treated 
RBL-2H3 cells were prepared for Western blot analyses and probed for PKCα, PKCβI, and actin as 
a loading control. The RBL-2H3 cells treated with siRNA targeting PKCα or βI and rescued by 
GFP-PKCα or βI overexpression were stimulated as described in C. Experiments in C–F were 
performed in triplicate, and error bars represent ± SD (*p < 0.05, **p < 0.1).
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comparable in each cell line (Figure 5A). 
Ionomycin-induced degranulation was en-
hanced in S23,24A-cofilin–expressing cells 
but unchanged in S23,24E-cofilin–express-
ing cells (Figure 5B, left). Similar results 
were obtained after antigen stimulation, 
although degranulation in S23,24E-cofilin 
cells was slightly inhibited (Figure 5B, right). 
These data demonstrate that reduced cofi-
lin phosphorylation at Ser-23 and Ser-24 
promotes degranulation in RBL-2H3 cells. 
Correspondingly, treatment with azelastine 
increased degranulation from both native 
RBL-2H3 cells (Figure 2D, left) and a cell 
line stably expressing a WT cofilin-DsRed 
fusion protein (Figures 5, C and D, left). In 
contrast, the effect of azelastine was abol-
ished by both mutations, as azelastine 
treatment did not alter ionomycin- or anti-
gen-induced degranulation in S23,24A-co-
filin and S23,24E-cofilin cell lines (Figure 5, 
C and D). These results indicate that phos-
phorylation of cofilin at Ser-23 and Ser-24 
by PKCα plays an important role in the 
control of excess histamine release.
Effect of the novel phosphorylation on 
cofilin activity
Previous studies showed that cofilin has sev-
eral complex functions, but we focused on 
two general biochemical functions: depo-
lymerizing actin filaments into actin mono-
mers (Carlier et al., 1997) and severing actin 
filaments to create free, barbed ends 
(Ichetovkin et al., 2000). In addition to its 
actin-binding ability, these functions of cofi-
lin are attenuated by LIMK-mediated phos-
phorylation at Ser-3 (Arber et al., 1998). In 
other words, phosphorylation of cofilin at 
Ser-3 leads to actin polymerization. There-
fore we examined whether phosphorylation 
at Ser-23 and Ser-24 also affected the actin-
depolymerizing and actin-severing activity 
of cofilin, via an F-actin sedimentation assay 
with wild-type or mutant forms of cofilin. 
When G-actin was polymerized to F-actin 
in the absence of cofilin and subjected to 
FIGURE 3: Identification of the PKCα substrate during the degranulation process. (A) Detection 
of proteins phosphorylated by cPKC during degranulation. The 32P-loaded RBL-2H3 cells were 
pretreated with or without 5 μM Gö6976 for 15 min and then stimulated with 5 μM ionomycin. 
The lysates were subjected to two-dimensional electrophoresis and autoradiography. The circles 
indicate proteins that were phosphorylated by cPKC during degranulation. (B) In vivo 
phosphorylation of cofilin-FLAG by cPKC. RBL-2H3 cells were transfected with cofilin-FLAG. 
Twenty-four hours later, the cells were stimulated with 1 μM ionomycin or 50 ng/ml DNP-BSA for 
5 min in the presence or absence of 5 μM Gö6976. Soluble proteins were immunoprecipitated 
via anti-FLAG affinity gel. The immunoprecipitated cofilin-FLAG was then detected by 
immunoblotting with an anti-FLAG antibody (bottom). The level of radioactivity was analyzed 
with a BAS-2500 bio-imaging analyzer (top), and the average phosphorylation level from three 
independent experiments is shown in the bottom graphs. Error bars and asterisks show the SD 
and probability relative to the control (i.e., no stimulation). *p < 0.05. (C) Effect of azelastine on 
ionomycin- and antigen-induced cofilin phosphorylation in vivo. RBL-2H3 cells were transfected 
with cofilin-FLAG. Twenty-four hours later, after preincubation with 10 μM or 50 μM azelastine 
for 15 min, the cells were stimulated with 1 μM ionomycin or 50 ng/ml DNP-BSA for 5 min and 
lysed. The phosphorylation level of the 
immunoprecipitated cofilin-FLAG was 
analyzed as described in B. (D) Effect of 
siRNA targeting PKCα on ionomycin- and 
antigen-induced cofilin phosphorylation in 
vivo. RBL-2H3 cells treated with siRNA for 
PKCα were transfected with cofilin-FLAG. 
Twenty-four hours later, the cells were 
stimulated with 1 μM ionomycin or 50 ng/ml 
DNP-BSA for 5 min and lysed. The 
phosphorylation level of the 
immunoprecipitated cofilin-FLAG was 
analyzed as described in B.
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in accordance with the method described in 
previous reports (Ichetovkin et al., 2000; Ono 
et al. 2004). When actin was polymerized in 
the presence of WT cofilin or S23,24A, the 
length of F-actin filaments was dramatically 
shortened compared with the control (Figure 
6B); this finding confirms that the nonphos-
phorylated form of cofilin possesses F-actin–
depolymerizing and/or F-actin–severing 
activity. Conversely, S23,24E cofilin was un-
able to depolymerize and/or sever F-actin 
(Figure 6B), suggesting that, in addition to 
Ser-3, the novel phosphorylation sites on 
cofilin are also important for its F-actin–
depolymerizing and/or F-actin–severing ac-
tivity. Furthermore, these results suggest that 
PKCα-mediated phosphorylation of cofilin 
contributes to actin polymerization during 
degranulation by regulating the F-actin–de-
polymerizating and/or F-actin–severing ac-
tivity of cofilin, which may be important for 
the proper termination of histamine release.
A previous report indicated that cofilin 
bound to 14-3-3ζ, which has been sug-
gested to play a dynamic role in the regula-
tion of cytoplasmic actin structure via the 
RKS23S24TP motif (Gohla and Bokoch, 2002). 
Therefore we tested the interaction be-
tween 14-3-3ζ and the cofilin mutants. The 
phosphorylation-mimic mutant (S23,24E) 
bound to 14-3-3ζ more strongly than WT, 
similar to the S3E mutant (Figure 6C). Con-
versely, the S23,24A mutant did not bind to 
14-3-3ζ, indicating that the Ser-23/Ser-24 
phosphorylation sites are important for 
the 14-3-3ζ binding. These results suggest 
that, in addition to Ser-3 phosphorylation 
by LIMK, PKCα phosphorylation-depen-
dent binding of cofilin to 14-3-3ζ somehow 
contributes to actin polymerization during 
degranulation.
PKCα-dependent actin polymerization 
during degranulation in vivo
To confirm the role of PKCα-mediated cofilin phosphorylation in the 
regulation of actin polymerization during degranulation, we visual-
ized actin polymerization in vivo using DsRed-actin. Before stimula-
tion, DsRed-actin showed two distributions, in which either a por-
tion of the DsRed-actin accumulated in the cortical region of the cell 
or there was equal distribution throughout the cytosol (Supplemen-
tal Figure S4A). The former pattern accurately represented cortical 
F-actin in the resting cells (Supplemental Figure S4A, green; Yanase 
et al., 2011), and the latter pattern seemed to be due to small por-
tion of DsRed-actin polymerized into cortical F-actin, in addition to 
a small amount of cortical F-actin itself (Supplemental Figure S4A). 
Because it was very hard to see the accumulation of DsRed-actin 
during degranulation in the cells exhibiting the former distribution 
due to masking of the fluorescence of newly polymerized DeRed-
actin by those formerly present in the cortical region, we chose cells 
exhibiting the latter distribution.
DsRed-actin accumulated at the plasma membrane in response 
to stimulation with ionomycin or antigen (Supplemental Figure S4B, 
ultra-high-speed centrifugation, a significant amount of F-actin was 
found in the pellet fraction (P); in contrast, a smaller amount of G-
actin was found in the supernatant (S) (Figure 6A, lanes 7 and 8). 
When WT cofilin was added before centrifugation, the amount of G 
actin increased and F-actin decreased because of the depolymeriz-
ing and/or severing activity of cofilin (Figure 6A, lanes 1 and 2). This 
distribution was not altered in the case of the S23,24A mutant 
(Figure 6A, lanes 3 and 4), indicating that it retained its actin-depo-
lymerizing and/or actin-severing activity. In contrast, in the case of 
the S23,24E mutant (Figure 6A, lanes 5 and 6), which mimics phos-
phorylated cofilin, an actin distribution was similar to that of control 
(no cofilin). Moreover, the amount of S23,24E cofilin that cosedi-
mented with F-actin was significantly decreased relative to both 
wild-type cofilin and the S23,24A mutant (Figure 6A, lanes 1–6, bot-
tom, and see “cofilin(ppt)” in the bottom graph). These results indi-
cate that actin-binding activity of cofilin was weakened when phos-
phorylated at Ser-23 and Ser-24, which abrogated its depolymerization 
and/or severing activity.
Next we compared effects of WT and mutant cofilin on length of 
actin filaments by direct observation of Alexa Fluor 488–labeled actin 
FIGURE 4: Determination of the PKCα phosphorylation site(s) in cofilin. (A) Mass spectrometric 
analysis of cofilin phosphorylated by purified PKCα in vitro. Purified MBP-cofilin was incubated 
with PKCα in the presence or absence of ATP, Ca2+, and PS/DO at 30°C for 15 min. After 
separation by SDS–PAGE, MBP-cofilin was subjected to mass spectrometry. The detected mass 
values for untreated (top) and ATP-treated cofilin (bottom) are shown. Spectra that were 
dependent on the presence of ATP are indicated by red boxes. The first peak is mono isotopic 
and the second is isotopic; detailed data are shown in Supplemental Figure S8. (B) In vitro 
phosphorylation of cofilin at Ser-23 and/or Ser-24 by PKCα. An in vitro kinase assay was 
performed with purified PKCα and MBP-cofilin wild-type (WT), the N-terminal–deletion mutant 
(Nd; lacking the N-terminal 24 amino acids), and the serine mutants (S3A, S23A, S24A, S23,24A) 
in the presence (+) or absence (–) of PKC activators. (C, D) The in vivo phosphorylation of cofilin 
at Ser-23 and Ser-24 during degranulation in RBL-2H3 cells. Plasmids of FLAG-tagged wild-type 
cofilin or the S3A, or S23,24A mutants were transfected into RBL-2H3 cells and then stimulated 
with 1 μM ionomycin (C) or 50 ng/ml DNP-BSA (D). (E) The in vivo phosphorylation of cofilin at 
Ser-23 and Ser-24 during degranulation in mouse BMMC. Plasmids of FLAG-tagged wild-type 
cofilin or the S3A or S23,24A mutants were transfected into BMMC cells and then stimulated 
with 1 μM ionomycin. Quantitative analysis of cofilin phosphorylation from three independent 
experiments is shown in the bottom graphs of B– E; bars represent SD. Quantification was 
performed by normalizing the radioactive bands in the kinase assay to the total amount of cofilin 
(*p < 0.05).
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top). However, this accumulation was abol-
ished by the F-actin–depolymerizing agent 
latrunculin A (Supplemental Figure S4B, 
middle), which indicated that the actin that 
accumulated at the plasma membrane was 
F-actin. Using this system, we investigated 
whether PKC could influence actin polymer-
ization during degranulation. Ionomycin- or 
antigen-induced actin polymerization was 
inhibited by treatment with Gö6976 (Sup-
plemental Figure S4B, bottom), indicating 
that cPKCs were involved in the polymeriza-
tion of actin. In addition, cotransfection of 
GFP-PKCαKN inhibited the polymerization 
of DsRed-actin; however, actin polymeriza-
tion was observed with PKCβI KN (Figure 7A 
and Supplemental Figure S5A), suggesting 
that actin polymerization was dependent on 
PKCα activity. The importance of PKCα in 
actin polymerization was confirmed by us-
ing azelastine, which inhibited actin polym-
erization in vivo without inhibiting PKCβI 
activation (translocation; Figure 7B and Sup-
plemental Figure S5B). In addition to the 
membrane accumulation, a ring-shaped ac-
cumulation of F-actin was observed (Supple-
mental Figure S6A, white arrows). To investi-
gate the ring-shape F-actin accumulation, 
we simultaneously visualized actin polymer-
ization and degranulation using GFP-actin 
and the DsRed-signal peptide. In response 
to ionomycin or antigen stimulation, the 
ring-shaped F-actin accumulation was found 
around the granules just after degranulation 
in a manner similar to PKCα (Supplemental 
Figure S6B). Therefore we compared the 
timing of the accumulation of both PKCα 
and actin polymerization. After ionomycin 
stimulation, actin was recruited immediately 
after PKCα accumulation (compare Figure 
7C at 114 and 125 s), and both proteins 
were colocalized near the area previously 
occupied by the granules (Figure 7C at 125 
s). In contrast, the ring-shaped F-actin did 
not colocalize with accumulated PKCβI 
(Figure 7D). Similar results were obtained in 
the case of the antigen stimulation (Supple-
mental Figure S4, C and D). More important, 
colocalization of the ring-shaped F-actin 
and PKCα, but not that of PKCβI, was con-
firmed by phalloidin staining and after scan 
analysis (Figure 7, E and F, and Supplemen-
tal Figure S5, E and F). The spatiotemporal 
difference between PKCα and βI strongly 
supports the importance of PKCα in actin 
polymerization during degranulation.
To further confirm the PKCα-dependent 
assembly of F-actin, we used quantitative 
fluorescence-activated cell sorting (FACS) 
and fluorescein isothiocyanate (FITC)–
phalloidin. In control treatments, the 
fluorescence peak was shifted to the right 
FIGURE 5: The effect of expression of cofilin mutants on degranulation. (A) Western blotting 
analyses of the expression of DsRed-cofilin WT and the S23,24A and S23,24E mutants. 
Approximately 50 μg of protein from each cell line stably expressing wild-type, S23,24A, or 
S23,24E was subjected to SDS–PAGE and Western blotting with anti-DsRed (top) and anti-actin 
(bottom) antibodies. After measuring the density of immunoreactive bands with ImageJ 
software (National Institutes of Health, Bethesda, MD) and normalizing the cofilin 
immunoreactive signal to that of actin, an average value ± SD was plotted in the bottom graph. 
(B) Each stable cell line was stimulated with 1 μM ionomycin or 50 ng/ml DNP-BSA for 15 min, 
and the percentage of β-hexosaminidase release was plotted. (C, D) After pretreatment with 
10 μM azelastine or no treatment, each stable cell line was stimulated with 1 μM ionomycin (C) 
or 50 ng/ml DNP-BSA (D) for 15 min; the percentage of β-hexosaminidase release was plotted. 
Asterisk indicates a significant difference relative to control release (WT, –AZ) with p < 0.05; 
number sign indicates difference between control (–AZ) and test (+AZ) with p < 0.05; AZ, 
azelastine; N.S., not significant. All experiments were performed in triplicate; error bars 
indicate SD.
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instead, depolymerization occurred within 
15 min after stimulation (Figure 8A, right). 
Statistical analysis of average values for 
FITC–phalloidin fluorescence, which reflects 
intracellular F-actin content, confirmed the 
importance of PKCα for actin polymeriza-
tion during degranulation. Ionomycin stimu-
lation significantly increased the mean fluo-
rescence in a time-dependent manner 
(Figure 8B, open column), whereas PKCα 
siRNA suppressed this increase (Figure 8B, 
closed column). Azelastine also abolished 
ionomycin-induced actin polymerization 
(Figure 8C). Similar results were obtained in 
the case of antigen stimulation (Supplemen-
tal Figure S7). Together with microscopy ob-
servations and the inhibitory effect of PKCα-
dependent phosphorylation of cofilin on 
degranulation described earlier, these re-
sults implicate a important role for PKCα in 
actin polymerization via phosphorylation of 
cofilin at novel sites (the ring-shaped accu-
mulation), which occurs at sites of exocyto-
sis just after degranulation and is necessary 
for rapid termination of histamine release.
DISCUSSION
Previous studies established that PKC acti-
vation is essential for mast cell degranula-
tion (Ozawa et al. 1993b). However, the role 
of the individual PKC isoforms in degranula-
tion has not been determined. In the pres-
ent study, experiments with the specific in-
hibitor azelastine showed that PKCα 
negatively regulates degranulation. We 
confirmed that azelastine directly inhibits 
PKCα but not PKCβI at low concentrations 
(between 1 and 10 μM) in vitro (Supplemen-
tal Figure S2A). However, azelastine has also 
been shown to inhibit histamine release and 
is a known antiallergy drug (Hide et al., 
1997, Shichijo et al., 1998). These discrep-
ancies may be the result of specific assay 
conditions, such as the concentration of 
azelastine, as concentrations of azelastine 
>10 μM also inhibit PKCβ in vitro (Supple-
mental Figure S2A). Alternatively, even if the 
same concentration of azelastine was used, 
the degree of cell permeability may have 
been different. Furthermore, it is notewor-
thy that the increased release of histamine 
was easily detectable in our system because 
the maximum release was lower than in pre-
vious reports. The maximal release from 
control cells was 34 ± 2% in this study, 
whereas it was ∼73% in a previous report 
(Hide et al., 1997). Of importance, the in-
hibitory effect of PKCα was confirmed via 
the adenoviral overexpression of PKCα KN 
and the PKCα-directed siRNA treatment. The inhibitory role of PKCα 
was further supported by the recruitment of PKCα immediately after 
secretion to the area where secretory granules had been located 
by ionomycin, indicating that actin polymerization occurred during 
degranulation (Figure 8A, left). However, in the case of siRNA 
treatment against PKCα, this rightward shift was not observed; 
FIGURE 6: Cofilin phosphorylation at Ser-23 and Ser-24 influences depolymerization of F-actin 
and binding to 14-3-3ζ. (A) The F-actin sedimentation assay. Purified wild-type (WT) cofilin, 
S23,24A (SA), and S23,24E (SE) were incubated with F-actin for 30 min. To serve as a negative 
control, F-actin was incubated alone (–). F-actin and F-actin–bound cofilin were precipitated via 
centrifugation, and the amounts of F-actin and cofilin in the supernatant (S) and pellet (P) were 
analyzed by SDS–PAGE and Coomassie blue staining. Quantitative analysis of amounts of cofilin 
and F-actin from three independent experiments is shown in the bottom graphs; bars represent 
SD. Quantification was performed by normalizing the density of bands in the assay to the 
amount of cofilin or actin in control (*p < 0.05). (B) Microscopic analyses of cofilin-induced 
F-actin depolymerization and/or severing. Alexa 488– or biotin-labeled actin filaments were 
incubated with purified MBP or MBP-cofilin wild-type, S23,24A, or S23,24E. Subsequently the 
filaments were tethered to a glass slide and observed via confocal microscopy. The result of 
quantitative analyses of the length of actin filaments in three independent experiments is shown 
in the lower graph (*p < 0.05). The experiments were performed in triplicate, and error bars 
represent ± SD. (C) Cofilin binding to 14-3-3ζ. Purified MBP-cofilin WT, S3A, S3E, S23,24A, or 
S23,24E was incubated with FLAG-14-3-3ζ for 60 min. Cofilin-bound 14-3-3ζ was pulled down 
with an anti-FLAG affinity gel and subjected to SDS–PAGE and Western blotting.
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and by F-actin being accumulated with simi-
lar timing as PKCα. In contrast, PKCβI, the 
other conventional PKC isoform expressed 
in RBL-2H3 cells, enhanced degranulation. 
In support of this finding, Nechushtan et al. 
(2000) demonstrated that PKCβ-deficient 
mice exhibit a decrease in degranulation. 
The recruitment of PKCβI to the vicinity of 
granules before degranulation suggests that 
PKCβI phosphorylates proteins located 
near secretory granules, such as soluble N-
ethylmaleimide–sensitive factor attachment 
protein receptors and other proteins that 
promote membrane fusion, including cal-
cium channels. Further experiments are nec-
essary to identify the substrate of PKCβI 
during degranulation.
We provided the first evidence that co-
filin, a major actin-remodeling protein, is a 
substrate of PKCα during degranulation in 
RBL-2H3 cells. In addition, we identified 
Ser-23 and Ser-24 of cofilin as major, novel 
sites of PKCα phosphorylation, although 
there may be an additional phosphoryla-
tion site(s) because Nd and S23,24A were 
slightly phosphorylated by PKCα in vitro 
and in vivo. Similar to phosphorylation at 
Ser-3 by LIMK, mimicking the phosphoryla-
tion of Ser-23 and Ser-24 inhibited the de-
polymerization and/or severing activity of 
cofilin and the binding ability to F-actin. 
Furthermore, the expression of the cofilin 
S23,24A mutant up-regulated degranula-
tion in RBL-2H3 cells, and actin polymeriza-
tion in vivo was dependent on PKCα activ-
ity. In addition, PKCα but not PKCβI 
colocalized with polymerized actin around 
the granules immediately after degranula-
tion. These results indicate that PKCα ac-
cumulates at sites of exocytosis, where it 
inactivates cofilin via Ser-23 and Ser-24 
phosphorylation, resulting in F-actin po-
lymerization; this relationship is summa-
rized in Figure 9. We propose that the 
FIGURE 7: Simultaneous observations of actin polymerization and PKCα or PKCβI during 
ionomycin-induced degranulation. (A) The effect of coexpression of wild-type or either kinase-
negative PKCα or PKCβI on actin polymerization in vivo. RBL-2H3 cells were transfected with 
DsRed-actin and either WT or KN of GFP-PKCα (left) or PKCβI (right). The cells were then 
treated with 1 μM ionomycin. The relative change in fluorescence of DsRed-actin at the plasma 
membrane in response to ionomycin is shown in the bottom graphs. *p < 0.05. (B) The effect of 
a PKCα inhibitor on actin polymerization. RBL-2H3 cells were transfected with DsRed-actin and 
GFP-PKCβI. After preincubation with 10 μM azelastine, cells were treated with 1 μM ionomycin. 
The relative change in fluorescence of GFP-PKCβI or DsRed-actin at the plasma membrane is 
shown in the bottom graph. (C, D) Comparison of F-actin localization with PKCα or PKCβI. 
RBL-2H3 cells were cotransfected with 
DsRed-actin and GFP-PKCα (C) or βI (D). 
After 24 h, the cells were treated with 1 μM 
ionomycin and were monitored using 
confocal microscopy. (E, F) Comparison of 
intact F-actin localization with PKCα or 
PKCβI. RBL-2H3 cells were transfected with 
GFP-PKCα (E) or βI (F). After 24 h, the cells 
were treated with 1 μM ionomycin and fixed. 
Intact F-actin was visualized using rhodamine-
phalloidin and monitored using confocal 
microscopy. Bottom graph shows profiles of 
fluorescence of GFP and rhodamine when 
line scan was performed, along with red 
arrow in the insets. White arrows indicate 
areas where PKCα or PKCβI accumulated. 
Bars, 10 μm.
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2002). Finally, actin polymerization appears 
to suppress excess degranulation. In fact, 
previous studies reported that cortical F-
actin serves as a barrier to prevent vesicular 
access to the plasma membrane (Frigeri 
and Apgar, 1999). Our data raise the pos-
sibility that accelerated actin polymeriza-
tion via the PKCα-mediated phosphoryla-
tion of cofilin may serve as a negative 
feedback mechanism in mast cell degranu-
lation. This hypothesis is in agreement with 
a previous report that PKC regulates the 
actin cytoskeleton in a wide range of cell 
types via the phosphorylation of actin-reg-
ulating proteins, including myristoylated 
alanine-rich C kinase substrate and ezrin/
radixin/moesin proteins (Larsson, 2006), 
which are involved in the regulation of exo-
cytosis (Bretscher et al., 2002).
Unfortunately, we could not rule out the 
possibility that PKCβI also phosphorylates 
cofilin, because treatments with LY333531 
and PKCβI siRNA inhibited degranulation; 
thus no events, including cofilin phosphory-
lation and actin polymerization, occurred. 
However, several findings indicate that 
PKCα but not PKCβI phosphorylates Ser-23 
and/or Ser-24 of cofilin, resulting in actin po-
lymerization to inhibit excess histamine re-
lease. 1) Actin polymerization was inhibited 
by PKCαKN but not PKCβI KN (Figure 4A). 
2) The accumulation of PKCα but not PKCβI 
was temporally and spatially coincident with 
F-actin accumulation around the area where 
granules had been located (Figure 4, C–F, 
and Supplemental Figure S5). 3) The stable 
cell line expressing the nonphosphorylated 
form of cofilin (S23,24A) resulted in an in-
crease in histamine release (Figure 5B), simi-
lar to the effect of azelastine, the overex-
pression of PKCαKN, and the siRNA 
treatment for PKCα (Figure 2, C–E). 4) Fur-
thermore, the effect of azelastine on hista-
mine release was abolished by the overex-
pression of the phosphorylated form of 
cofilin (S23,24E; Figure 5, C and D).
We used S23,24A and S23,24E mutants 
to test our hypothesis that both serines are 
phosphorylated; this hypothesis was de-
rived from the finding that a single point 
mutation of Ser-23 or Ser-24 did not com-
pletely abolish phosphorylation. Indeed, a 
recent report of the phospho-proteome of 
human embryonic stem cells showed that 
both Ser-23 and Ser-24 of human cofilin 
were phosphorylated (Rigbolt et al., 2011). 
However, we still do not know whether 
both Ser-23 and Ser-24 are simultaneously 
phosphorylated in one molecule. Of inter-
est, cofilin mutants (S23E and S24E) in which Ser-23 or Ser-24 
was replaced with glutamic acid also lost the ability to sever and/
or depolymerize F-actin (unpublished data). Furthermore, the 
preferential binding of phospho-cofilin to 14-3-3ζ also plays an 
important role in F-actin polymerization because 14-3-3ζ regulates 
actin dynamics by stabilizing phospho-cofilin (Gohla and Bokoch, 
FIGURE 8: PKCα-dependent actin polymerization during ionomycin-induced degranulation. 
(A) Histograms of FACS analyses. Cells transfected with PKCα siRNA and control RBL-2H3 were 
stimulated with ionomycin, and actin polymerization was monitored with FITC-phalloidin via 
FACS. Red lines indicate the position of the peak at 0 min. (B) Statistical analysis of PKCα-
dependent actin polymerization. The same experiments described in A were performed three 
times, and the mean of the fluorescence intensity for each FITC histogram is shown, together 
with the SD. Asterisk indicates significant differences relative to the control at 0 min, with 
p < 0.05, and number sign indicates significant differences between the control (–AZ or –PKCα 
siRNA) and test (+AZ or +PKCα siRNA) conditions, with p <0.05. (C) Effect of azelastine on actin 
polymerization. RBL-2H3 cells were pretreated with or without azelastine for 15 min and 
stimulated with 1 μM ionomycin in the presence of the inhibitor. Data analysis was performed as 
described in B.
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in the inactivation of cofilin. In contrast, Ser-23 and Ser-24 are 
located between α1 and α2 helices and do not appear to directly 
interact with the β4 sheet in the 3D structure. Accordingly, phospho-
rylation at Ser-23 and/or Ser-24 allosterically regulates the positional 
relationship between the β4 sheet and the N-terminus around Ser-3, 
resulting in cofilin inactivation.
Our finding raises one more question regarding why other phos-
phorylation site(s) in addition to Ser-3 are necessary to regulate cofi-
lin function. In platelet degranulation, the dephosphorylation of co-
filin at Ser-3 (activation) occurs rapidly in an initial phase, and it 
is subsequently slowly rephosphorylated by LIMK-1 (inactivation) 
(Pandey et al., 2006, 2009). Dephosphorylation seems to occur 
through the calcineurin-dependent activation of slingshot (Wang 
et al., 2005). Although the involvement of cofilin dephosphorylation 
in histamine release was not reported, it seems to occur in mast 
cells, judging from the finding that actin depolymerization is gener-
ally necessary for an initial phase of secretion and the report that 
calcineurin is involved in the FcεRI-mediated exocytosis from RBL 
mast cells (Hultsch et al., 1998). However, unlike degranulation from 
platelets, the inactivation of cofilin should occur rapidly in histamine 
release to avoid a hyperallergic response. In the process, an addi-
tional regulation system of cofilin by PKCα may be developed. 
Indeed, an optimal sequence alignment indicates that Ser-23 and 
Ser-24 are only conserved for mammals and birds, although Ser-24 
is also conserved in reptiles (Table 1), in which the presence of hista-
mine in mast cells has been reported (Mulero et al., 2007). Of impor-
tance, these conserved serine residues share the PKC phosphoryla-
tion consensus sequence (K/R)-X-(S/T). In contrast, Ser-3, which is 
phosphorylated by LIMK (but not by PKC), is conserved between 
fish and mammals. These facts suggest that the PKC-mediated reg-
ulation of cofilin may be specific for the release of histamine in 
higher animals, for which rapid polymerization may be necessary to 
immediately halt secretion. Indeed, azelastine treatment did not en-
hance the secretion of catecholamine from chromaffin cells (unpub-
lished data). Conversely, phosphorylation at Ser-3 by LIMK may play 
some role in fundamental actin remodeling. To answer the question, 
further experiments to compare the effect of phosphorylation on the 
kinetics of actin and 14-3-3ζ binding to cofilin and/or its severing 
activity would be necessary. Furthermore, the regulation of actin by 
cofilin is more complicated. For example, a positive role of F-actin 
polymerization in degranulation has been reported (Pendelton and 
Koffer, 2001). In addition, cofilin is regulated not only by phosphory-
lation but also other factors, including phosphatidylinositol 4,5-bis-
phosphate and pH (van Rheenen et al., 2007; Pope et al., 2004). 
degranulation of cell lines stably expressing S23A or S24A was 
up-regulated (unpublished data). These results suggest that at 
least a single phosphorylation event at Ser-23 or Ser-24 is enough 
to regulate cofilin function in histamine release, and only single 
phosphorylation may occur in some cases. Of interest, Ser-24 cor-
responds to the phospho-Ser in the prototypical 14-3-3 recogni-
tion motif RSXpSP (Fu et al., 2000). Indeed, S24E preferentially 
bound to 14-3-3ζ, whereas S23E did not (unpublished data). Ser-
24 is conserved among cofilin-1, cofilin-2, and actin-depolymeriz-
ing factor (Table 1), suggesting that Ser-24 is more important than 
Ser-23.
How can this novel phosphorylation pattern regulate cofilin func-
tion? Ser-3 is located in the N-terminus close to the β4 sheet, which 
is important for actin binding, in the three-dimensional structure 
(Pope et al., 2004). The substitution of Ser-3 to Asp affects the spa-
tial relationship between the N-terminus and the β4 sheet, resulting 
FIGURE 9: A model for preventing excess degranulation via 
PKCα-mediated cofilin phosphorylation. The aggregation of FcεRI 
triggers PKCα activation, resulting in phosphorylation of cofilin at 
Ser-23 and/or Ser-24. The novel phosphorylation results in inactivation 
of cofilin, leading to an increase in cortical F-actin polymerization, 
which is necessary to prevent excess degranulation. Phosphorylation 
strengthens cofilin binding to 14-3-3ζ, contributing to the system. To 
simplify, cortical F-actin in the resting state and actin depolymerization 
at early phase are omitted in the model. Newly polymerized F-actin is 
indicated with red arrows.
19      23 24    28
Human Cofilin-1 K V R K S ST P E E
Cofilin-2 K V R K S ST Q E E
Actin-depoly-
merizing factor
K V R K C S T P E E
Mouse Cofilin-1 K V R K S S T P E E
Chicken Cofilin-1 K V R K S S T P E E
Gecko Cofilin-1 K V R K C S T P E E
Frog Cofilin-1 K V R H P L S P E E
Zebrafish Cofilin-1 R V R L Q G T D E K
The alignment of the conserved PKC consensus sites is shown with red letters; 
those residues are identified as novel phosphorylation sites by PKCα.
TABLE 1: Sequence alignment of cofilin within vertebrates.
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0.5 μg/ml IgE. The cells were then washed twice and treated with 
DNP-BSA for 15 min at 37°C. The supernatants were transferred to 
96-well plates and incubated with β-hexosaminidase substrate 
(1 mM p-nitrophenyl-N-acetyl-d-glucosaminide) for 1 h at 37°C. To 
stop the reaction, 0.2 M Tris was added, and the absorbance at 
405 nm was measured.
Construction of plasmids encoding wild-type 
and cofilin mutants
The cDNA fragments of cofilin with EcoRI site at the N-terminus and 
the C-terminus were produced via PCR using mouse cofilin-hexahis-
tidine in pUDC2SRα. The primers were 5′-TTGAATTCATGGCCTCT-
GGTGTG-3′ and 5′-TTGAATTCTCACAAAGGCTTGCCC-3′. The 
PCR products were first subcloned into a pUC118 vector (Takara, 
Shiga, Japan). After digestion with EcoRI, the cDNA encoding cofi-
lin was subcloned into the EcoRI site in the pMAL-2c (New England 
BioLabs, Ipswich, MA), in the p3xFLAG-CMVTM-14 (Sigma-Aldrich), 
or in the pDsRed monomer vector (Clontech, Palo Alto, CA).
The cDNA encoding the mutants lacking 24 N-terminal amino 
acids were produced via PCR with the following primers: 
5′-CCGAATTCCCAGAAGAAGTGAAGA-3′ and 5′-TTGAATTCT-
CACAAAGGCTTGCCC-3′. The PCR products were cloned into 
pMAL-2c as described. In addition, point mutants of cofilin were 
produced via site-directed mutagenesis according to the manufac-
turer’s instructions with the Quick Change II XL site-directed muta-
genesis kit (Stratagene, La Jolla, CA), using mouse cofilin and 
DsRed monomer in p3xFLAG-CMV-14 or in pMAL-2c as the tem-
plate. The sense and antisense primers used were as follows: 
for S23A cofilin, 5′-GGTTCGCAAGGCCTCAACACAAG-3′ 
and 5′-CTGGTTTGAGGCCTTGCGAACC-3′; for S24A cofilin, 
5′-GGTTCGCAAGAGCGCTACACCAGAAG-3′ and 5′-CTTCTG-
GTGTAGCGCTCTTGCGAACC-3′; for S23,24A cofilin, 5′-GGT-
TCGCAAGGCAGCAACACCAGAAG-3′ and 5′-CTTCTGGTGTT-
GCTGCCTTGCGAACC-3′; for S3E cofilin, 5′-ATTTCAGAATTCAT-
GGCCGAGGGTGTGGCTGTCTCTGAT-3′ and 5′-ATCAGAGACA-
GCCACACCCTCGGCCATGAATTCTGAAAT-3′; and for S23,24E 
cofilin, 5′-TTCAATGACATGAAGGGTTCGAAAGGAGGAGACAC-
CAGAAGAAGTGAAG-3′ and 5′-CTTCACTTCTTCTGGTGTCTC-
CTCCTTTCGAACCTTCATGTCATTGAA-3′. All PCR products were 
verified by sequencing.
RNA isolation and construction of β-hexosaminidase 
signal peptide-DsRed
Total mRNA was isolated from the cells with TRIzol reagent (Life 
Technologies, Grand Island, NY) according to the manufacturer’s 
protocol. The mRNA was reverse transcribed to cDNA using 
random hexamers and Thermoscript thermostable reverse 
transcriptase (Invitrogen). Primers, 5′-GCTAGCATGGCCGGCTG-
CAGGCTCTGG-3′ and 5′-GCTAGCGCAGTCTGCTCAAACTCCT-
GCTC-3′, were used to amplify β-hexosaminidase in the presence 
of Taq polymerase. The PCR product was ligated into the pGEM-T 
Easy Vector (Takara). The signal peptide of β-hexosaminidase 
was amplified via PCR and cloned into AseI and BamHI sites of 
pWDsRed2-N1 (modified Clontech pDsRed2-N1). All PCR prod-
ucts were verified by sequencing.
Construction of adenovirus vectors encoding 
GFP-PKCα and βI
After digestion with XbaI and XhoI, the respective cDNA fragments 
encoding GFP-PKCα or βI were subcloned into the XbaI and XhoI 
sites of the pShuttle-cytomegalovirus vector. After linearization by 
Pme I, the pShuttle vector containing cDNA encoding a fusion 
These facts indicate a complex role of actin polymerization at dif-
ferent stages or different areas of degranulation through a well-
regulated mechanism. Further experiments to investigate actin 
polymerization and cofilin phosphorylation temporally and locally 
would be helpful to understand the comprehensive role of actin 
and cofilin in degranulation. In future studies, DsRed-Signal pep-
tide and DsRed-actin would be useful, and our finding that cofilin 
is regulated by additional phosphorylation sites at Ser-23 and Ser-
24 is important.
In conclusion, PKCα phosphorylates cofilin at Ser-23 and/or Ser-
24 during degranulation. Furthermore, these novel PKC-mediated 
phosphorylation events regulate F-actin remodeling by modifying 
the ability of cofilin to bind to 14-3-3ζ and depolymerize and/or 
serve F-actin. This highly regulated mechanism is necessary for the 
termination of degranulation and appears to have been developed 
specifically for histamine release.
MATERIALS AND METHODS
Materials
Ionomycin and Gö6976 were purchased from Calbiochem (La Jolla, 
CA). DNP-specific IgE (clone SPE7), DNP-BSA, p-nitrophenyl-N-
acetyl-β-d-glucosaminide, anti-FLAG M2 monoclonal antibody, and 
anti-FLAG M2 Affinity Gel were obtained from Sigma-Aldrich (St. 
Louis, MO). [γ-32P]ATP and monosodium [γ-32P]phosphate were 
products of MP Biomedicals (Irvine, CA). Azelastine was kindly do-
nated by Eisai (Tokyo, Japan). LY333531 was obtained from Axon 
Medchem (Groningen, Netherlands). Mouse cofilin-hexahistidine in 
pUDC2SRα was described previously (Yang et al., 1998). The cDNA 
encoding GFP, GFP-PKCα and βI and kinase-negative mutants were 
prepared as described previously (Sakai et al., 1997; Shirai et al., 
1998).
Cell culture and protein overexpression 
and down-regulation
RBL-2H3 cells were grown in RPMI 1640 (Nacalai Tesque, Kyoto, 
Japan) supplemented with 10% FBS (Sigma-Aldrich), 100 U/ml peni-
cillin, and 100 μg/ml streptomycin (GIBCO, Grand Island, NY) in 
a 37°C humidified atmosphere containing 5% CO2. Transient 
transfections of plasmids were performed with Fugene6 (Roche, 
Basel, Switzerland) or via electroporation (Amaxa; Lonza, Basel, 
Switzerland) according to the manufacturer’s protocol. In the case of 
adeno virus infection, 2 × 105 RBL-2H3 cells were seeded in a 3.5-cm 
glass-bottom dish (MatTek, Ashland, MA) with 2 ml of medium 1 d 
before the infection. After removal of the medium, a high-titer virus 
solution (multiplicity of infection >5) in 100 μl OPTI-MEM was added 
to the dish. After 4 h of incubation, the medium was changed to 
RPMI 1640, and the cells were incubated overnight.
For down-regulation of PKCα and βI, RBL-2H3 cells were trans-
fected with siRNA at a final concentration of 100 nM using Lipo-
fectamine 2000 transfection reagent (Invitrogen, Carlsbad, CA) ac-
cording to the manufacturer’s instructions. The siRNA sequences 
were as follows: 5′-CACGAGGGCAGCCUGUCUUAA-3′ and 
5′-UUAAGACAGGCUGCCCUCGUG-3′ were used for rat PKCα and 
5′-CGGUGCGCUUCGCCCGCAATT-3′ and 5′-UUGCGGGC-
GAAGCGCACCGTG-3′ were used for rat PKCβ. Control scramble 
siRNA oligos were purchased from Qiagen (Valencia, CA) and trans-
fected into cells as a negative control.
Degranulation assay
RBL-2H3 cells (5.0 × 105/ml) were incubated overnight. Without any 
pretreatment, the cells were treated with ionomycin for 15 min at 
37°C. For antigen stimulation, the cultures were incubated with 
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chromatography/mass spectrometry/mass spectrometry (LC/MS/MS) 
using a high-performance liquid chromatography system (Paradigm 
MS4; Michrom Bioresources, Auburn, CA) coupled to a linear ion trap 
mass spectrometer (Finnigan LTQ; Thermo Scientific, San Jose, CA). 
LC/MS/MS data were interpreted through the MASCOT MS/MS ions 
search (Matrix Science, London, United Kingdom).
Identification of phosphopeptide by mass spectrometry
In-gel reduction-alkylation and in-gel digestion of the MBP-cofilin 
bands excised from a Coomassie brilliant blue–stained SDS gel 
were performed as described. After desalting with ZipTipC18 
(Millipore, Billerica, MA), positive-ion mass spectra of peptide frag-
ments were acquired in a Micromass Q-Tof2 mass spectrometer 
(Waters Corporation, Milford, MA) equipped with a direct infusion 
nano electrospray ionization source.
Expression and purification of recombinant protein
The cDNAs encoding wild-type cofilin or mutants were digested 
with EcoRI and subcloned into the EcoRI site of pMal-2c. BL21 (DE3) 
pLys cells were used to express MBP-fusion proteins, which was in-
duced with 0.3 mM isopropyl 1-thio-d-galactoside at 25°C for 4 h. 
The cells were then harvested and lysed in column buffer (20 mM 
Tris-HCl, pH 7.4, 1 mM EDTA, 1 mM dithiothreitol, 200 mM NaCl, 
1% Triton X-100, 20 μg/ml leupeptin, 1 mM phenylmethylsulfonyl 
fluoride) with a handy sonic instrument (Tomy Seiko, Tokyo, Japan). 
After centrifugation at 10,000 × g for 1 h, fusion proteins were puri-
fied on an amylose resin (New England BioLabs, Ipswich, MA) affin-
ity column, according to the manufacturer’s instructions.
In vitro cofilin phosphorylation assay
Purified MBP-cofilin was incubated with purified PKCα at 30°C in 
the presence or absence of 8 μg/ml PS, 0.8 μg/ml (±)-1,2-dide-
canoylglycerol (DO), and 0.5 mM CaCl2. This reaction was initiated 
by the addition of 0.2 mM ATP with [γ-32P]ATP. After 15 min, the re-
action was terminated via addition of sample buffer (186 mM Tris-
HCl, pH 6.7, 15% glycerol, 9% SDS, 6% 2-mercaptoethanol, bro-
mophenol blue) and boiling at 95°C for 5 min. The amount and ra-
dioactivity of MBP-cofilin were monitored by SDS–PAGE in 
conjunction with immunoblotting and autoradiography with a BAS-
2500 analyzer (Fujifilm, Tokyo, Japan).
In vivo cofilin phosphorylation assay
RBL-2H3 cells were transfected with cofilin-FLAG and its mutants. In 
the case of DNP-BSA stimulation, 1 μl of 100 μg/ml IgE was added 
to medium (final concentration of 50 ng/ml) 1 d before the examina-
tion. For overnight culture after transfection, the cells were loaded 
with 32P for 1 h and were stimulated with ionomycin or DNP-BSA for 
1 min. The cells were harvested and lysed in lysis buffer (20 mM Tris-
HCl, pH 7.4, 10 mM ethylene glycol tetraacetic acid [EGTA], 2 mM 
EDTA, 150 mM NaCl, 200 μM leupeptin, 1 mM phenylmethylsulfo-
nyl fluoride, 1 mM Na3VO4, 1 μg/ml pepstatin, and 20 mM β-
glycerophosphate) containing 1% Triton X-100; subsequently the 
cells were sonicated. After centrifugation, the supernatant was im-
munoprecipitated with an anti-FLAG M2 affinity gel and subjected 
to SDS–PAGE, autoradiography, and immunoblotting with an anti-
FLAG antibody.
Generation of stable cell lines
Plasmids encoding mDsRed-cofilin and each mutant were trans-
fected via the Amaxa Nucleofector System in accordance with the 
manufacturer’s instructions. Geneticin (0.5 mg/ml) was added to the 
medium 24 h posttransfection. After being cultured for more than 
protein of GFP with PKCα or βI or its mutant was coelectroporated 
with a pAdEasy backbone vector into BJ5183 bacterial cells. The 
recombination was verified via a Pac1 digestion, and the plasmid 
was purified by CsCl banding. Approximately 10 μg of the purified 
plasmids was digested by Pac1 and transfected with FuGENE 
6 (Roche) into 50–70% confluent HEK293 cells plated on a 6-cm 
dish. The cells were scraped on day 7 posttransfection and resus-
pended in 1 ml of phosphate-buffered saline(–). After sonication, 
50–70% confluent HEK293 cells in a T75 flask were infected with the 
supernatant and cultured in DMEM supplemented with penicillin 
(100 U/ml), streptomycin (100 μl/ml), and 10% horse serum (Life 
Technologies). To further amplify the viruses, we repeated infection 
using 30–50% of the viral supernatant on 50–70% confluent HEK293 
cells in T75 flasks at least five times. Finally, the adenovirus was puri-
fied via CsCl banding and titrated.
Confocal microscopy
RBL-2H3 cells expressing signal peptide-DsRed and GFP-PKCα or 
βI were seeded onto a glass-bottom culture dish (MatTek) and in-
cubated for 24 h before observation. In the case of stimulation of 
DNP-BSA, 1 μl of 100 μg/ml IgE was added to medium (final 
50 ng/ml) 1 d before the examination. The culture medium was 
replaced with Siraganian buffer (119 mM NaCl, 5 mM KCl, 0.4 mM 
MgCl2, 5.6 mM glucose, 1 mM CaCl2, 0.1% BSA, and 25 mM 
1,4-piperazinediethanesulfonic acid, pH 7.4). Translocation of sig-
nal peptide-DsRed and GFP-tagged PKCα or βI was triggered by 
direct addition of 10 μM ionomycin or 500 ng/ml DNP-BSA into 
the Siraganian buffer to yield a final concentration of 1 μM or 
50 ng/ml. GFP fluorescence was monitored via a confocal laser 
scanning fluorescence microscope (LSM 510 invert; Carl Zeiss, 
Jena, Germany) with a 488-nm argon laser excitation and a 515- to 
535-nm bandpass barrier filter. Red fluorescence was monitored at 
543-nm HeNe excitation using a 560-nm long-pass barrier filter. To 
qualify the membrane translocation, >10 cells were analyzed via 
line scanning, and the percentage of membrane fluorescence of 
that total was estimated.
Two-dimensional electrophoresis
For the first dimension, immobilized pH gradient (IPG) dry strip gels 
(pH 3–10 and a length of 13 cm or pH 4–7 and a length of 13 cm; 
GE Healthcare Amersham Biosciences, Tokyo, Japan) were rehy-
drated with 280 μl of 32P-labeled protein sample containing 1 mg of 
protein in IPG strip holders (GE Healthcare Amersham Biosciences) 
for 10 h. The temperature was maintained at 20°C. Isoelectric focus-
ing (IEF) was then conducted to a total of 65,500 Vh. After IEF, IPG 
gels were equilibrated with buffer containing 6 M urea, 50 mM Tris-
HCl (pH 8.8), 30% glycerol, 10 mg/ml dithiothreitol, and 2.0% SDS 
for 15 min at room temperature. For the second dimension of sepa-
ration, the equilibrated IPG dry strip gels were applied to 12.5% 
polyacrylamide gradient gels, and SDS–PAGE was performed.
In-gel digestion and mass spectrometry 
for protein identification
After electrophoresis, silver-stained spots corresponding to proteins 
were excised and destained. For reduction-alkylation reactions, ex-
cised bands were incubated with 10 mM dithiothreitol in 25 mM 
ammonium bicarbonate for 45 min at room temperature and then 
with 0.1 M iodoacetamide in 50 mM ammonium bicarbonate for 
60 min at 50ºC. Proteins in gels were digested with porcine trypsin 
(sequencing grade; Promega, Madison, WI) in 50 mM ammonium 
bicarbonate for 15 h at 37ºC. The peptide fragments were extracted 
from gels, concentrated in vacuo, and then subjected to liquid 
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24 h, the transfected cells were transferred to 96-well plates at a 
density of 1 cell/well for cloning. Positive clones were identified by 
fluorescence detected using confocal microscopy.
F-actin cosedimentation assay
The F-actin sedimentation assay was performed as described by 
Moriyama et al. (1996). Briefly, 2 mg/ml actin from rabbit muscle 
(Molecular Probes, Eugene, OR) was polymerized for 60 min at room 
temperature in 10× polymerization buffer (0.2 M Tris-HCl, pH 7.5, 1 M 
KCl, 20 mM MgCl2, and 1 mM dithiothreitol). After purification of 
MBP-cofilin and mutants, MBP was excised by factor Xa (Novagen, 
Gibbstown, NJ) and removed with amylose resin. Purified cofilin 
(5 μg of wild type or mutant) was incubated with 10 μg of F-actin in 
200 μl of 10 mM Tris-HCl (pH 8.0) for 30 min at room temperature. 
Then, the mixtures were ultracentrifuged at 100,000 × g for 30 min. 
The supernatants and pellets were separately subjected to SDS–
PAGE and stained with Coomassie blue.
Direct observation of F-actin severing
The F-actin–severing assay was performed as previously described 
(Ono et al. 2004). Briefly, unlabeled actin (1.4 μM), Alexa Fluor 
488–labeled actin (0.4 μM, Molecular Probes), and biotin-labeled 
actin (0.2 μM; Cytoskeleton, Dover, CO) were copolymerized for 1 h 
in ISAP buffer (50 mM KCl, 20 mM 4-(2-hydroxyethyl)-1-pipera-
zineethanesulfonic acid–KOH, 5 mM EGTA, 2 mM MgCl2, 1 mM 
ATP, and 1 mM dithiothreitol, pH 7.2). Slide glass (76 × 26 mm; 
Matsunami, Osaka, Japan) was coated with 0.1% nitrocellulose in 
methanol. The cover glass (24 × 32 mm; Matsunami) was mounted 
on the coated glass slide to form a perfusion chamber. The chamber 
was perfused with 30 μg/ml anti-biotin antibody and washed twice 
with ISAP buffer containing 0.5 mg/ml BSA. Alexa Fluor 488/biotin–
labeled F-actin was diluted 30-fold with anti-bleaching buffer (ISAP 
buffer containing 36 μg/ml catalase, 20 μg/ml glucose oxidase, 
6 mg/ml glucose, and 100 mM dithiothreitol). After preincubation 
with purified cofilin or its mutants, the mixture was perfused into 
the chamber and incubated for 5 min. After washing twice with 
anti-bleaching buffer, fluorescence was monitored via confocal 
microscopy.
F-actin FACS Assay
In total, 2 × 106 RBL cells were transfected with 100 ng/ml siRNA in 
a 10-cm dish. After trypsinization and fixation with 70% ethanol, the 
cells were stained with FITC-phalloidin (Molecular Probes). Appro-
priate numbers of cells were subjected to analysis with a FACScan 
(BD Biosciences, San Diego, CA). To compare the cellular F-actin 
content, a ratio of the mean fluorescence intensity of FITC-phalloi-
din staining was plotted as “relative to F-actin.”
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Supplementary methods 
 
In Vitro PKC Kinase Assay 
Kinase assays of purified GST-tagged PKC  and I from sf9 cells were 
performed as described previously (Sakai et al., 1997). Briefly, the kinase activity 
was assayed by measuring the incorporation of 32P into myelin basic protein from 
[-32P]ATP in the presence of 8 g/ml PS (Sigma), 0.8 g/ml 
(±)-1,2-didecanoylglycerol (DiC10, BIOMOL, Plymouth Meeting, PA), and 50 M 
Ca2+.  
 
Immunocytochemistry 
1 x 105 of the RBL-2H3 cells were seeded in the 3.5 cm glass-bottom dish 
with 2 ml of the medium a day prior to the transfection. To compare localization 
between DsRed-signal peptide and histamine, RBL-2H3 cells were transfected with 
DsRed-signal peptide by Fugene (Roche) as described in Materials & Methods. The 
cells fixed at appropriate time points by 4%paraformaldehyde and 0.2% picric acid 
in 0.1 M phosphate buffer were permeabilized with 0.3% TritonX-100/PBS for 30 
min at room temperature, and blocked for 1h with 10% normal goat serum (NGS) in 
PBS. The cells were incubated for 1 h with anti-Histamine antibody (PROGEN, 
Heidelberg, Germany) diluted with 0.03% Triton X-100/PBS (PBS-T) at a 1: 200. 
FITC-conjugated anti-rabbit IgG (MolecularProbes) was used for secondary 
antibody. After washing cells with PBS, both the fluorescence of FITC and DsRed 
were observed under confocal microscopy as described in Materials & Methods. 
 
 
  
Supplementary figure legends 
 
Figure S1. The distinct role of PKC and PKCI in the antigen-induced 
degranulation. 
(A and B) Representative images of antigen-induced degranulation and the 
translocation of GFP-tagged PKC and I. RBL-2H3 cells were co-transfected with 
the WDsRed-fused signal peptide of -hexosaminidase and GFP-PKC (A) or I (B). 
After 24h, the cells were treated with 50 ng/ml DNP–BSA and monitored using 
confocal microscopy. White arrows point to secreting granules. (C) Effect of 
overexpression of wild type (WT) or kinase negative (KN) PKC on the 
antigen-induced degranulation(left graph) and that of WT or KN PKC (right 
graph)RBL-2H3 cells were infected with adenovirus encoding GFP-tagged WT or 
KN PKC, and with those of WT or KN PKC The cells were stimulated with 50 
ng/ml DNP–BSA for 15 min, and the percentage of -hexosaminidase release was 
plotted. (D) Effect of specific inhibitors for PKC and I. RBL-2H3 cells were 
pretreated with azelastine or LY333531, and stimulated as described in C.  (E) 
Effect of knockdown of PKC orI by siRNA. RBL cells were transfected with 
siRNA specific for PKC or I and stimulated as described in C. * and ** show 
significant differences with P<0.05 and Ｐ<0.1, respectively. Experiments in (C) 
and (E) were independently performed in three times and error bars indicate ± SD.  
 
Figure S2.  Specificity of azelastine between PKC and I. 
(A) Effect of azelastine on the activity of PKC or I. Purified PKC and PKCI 
prepared from the baculovirus expression system were incubated with azelastine 
for 15min at 30 oC in the presence of ATP, Ca2+ and PS/DO. 32P incorporation was 
determined using a scintillation counter.  
 (B) Effect of azelastine on the translocation of PKC or I. RBL-2H3 cells were 
co-transfected with GFP-tagged PKC and WDsRed-PKCI. After preincubation 
with or without (control) 10 M azelastine for 15 min, the cells were stimulated with 
1 M ionomycin. Translocation of PKCs was monitored using confocal microscopy. 
The relative fluorescence change of GFP-PKC and WDsRed-PKCI on the plasma 
membrane by ionomycin is shown in the bottom graphs. *P<0.01 and **Ｐ<0.05. 
The experiment was performed in triplicated, and error bars indicate ± SD. 
 
Figure S3. In vitro and in vivo phosphorylation assay using S3A mutant cofilin 
(A) In vitro phosphorylation of cofilin except for Ser3 by PKC. An in vitro kinase 
assay was performed with purified PKC and MBP-cofilin wild-type (WT) and 
the serine mutants (S3A) in the presence (+) or absence (-) of PKC activators. (B) 
The in vivo phosphorylation of cofilin at Ser23 and Ser24 during degranulation 
in mouse BMMC induced by antigen stimulation. Plasmids of FLAG-tagged 
wild-type cofilin or the S3A, or S23,24A mutants were transfected into BMMC 
cells and then stimulated with 50 ng/ml DNP-BSA.  Quantitative analysis of 
cofilin phosphorylation from three independent experiments is shown in the 
bottom graph; bars represent SD. Quantification was performed by normalizing 
the radioactive bands in the kinase assay to the total amount of cofilin 
(*P<0.05). 
Figure S4. The visualization of in vivo actin polymerization during degranulation. 
(A) Representing images of WDsRed-actin in the resting RBL-2H3 cells. (B) Effect of 
latrunculin and cPKC inhibitor on the in vivo actin polymerization. RBL-2H3 
cells transfected with WDsRed-actin were pretreated with or without 
latrunculin A or Gö6976, and then stimulated with 1 M ionomycin or 50 ng/ml 
DNP-BSA.  
 
Figure S6. Simultaneous observations of actin polymerization and PKC or PKCI 
during antigen-induced degranulation. 
(A) The effect of co-expression of wild type or the kinase negative PKC or PKCI on 
actin polymerization. RBL-2H3 cells were transfected with WDsRed-actin and WT 
(upper) or KN form (bottom) of GFP-PKC (left) or PKCI (right). Cells were then 
treated with 50 ng/ml DNP-BSA. The relative fluorescence change of DsRed-actin 
on the plasma membrane is shown in the bottom graphs.  (B) The effect of PKC 
inhibitor on actin polymerization. RBL-2H3 cells were transfected with 
WDsRed-actin and GFP-PKCI. After preincubation with 10 M azelastine, cells 
were treated with 50 ng/ml DNP-BSA. The relative fluorescence change of 
GFP-PKCI and DsRed-actin on the plasma membrane is shown in the bottom 
graph.   (C and D) Comparison of localization of F-actin and PKC or PKCI 
RBL-2H3 cells were co-transfected with WDsRed-actin and GFP-PKCC or I (D). 
After 24h, the cells were treated with 50 ng/ml DNP-BSA, and monitored using 
confocal microscopy. (E and F) Comparison of intact F-actin localization with PKC 
or PKCI.RBL-2H3 cells were transfected with GFP-PKCE or I (F). After 24 h, 
the cells were treated with 50 ng/ml DNP-BSA and fixed. Intact F-actin was 
visualized using rhodamine-phalloidin and monitored using confocal microscopy. 
Bottom graph shows profiles of fluorescence of GFP and rhodamine when line 
scanned was performed along with red arrow in the insets. White arrows point to 
granules where PKC or PKCI accumulated. 
 
Figure S6. The accumulation of F-actin around granules immediately after 
degranulation. 
(A) Round shape accumulation of F-actin during degranulation. 
RBL-2H3 cells were transfected with WDsRed-actin and GFP. The cells 
were treated with 1 M ionomycin (left) or DNP-BSA (right), and monitored 
using confocal microscopy. White arrow indicates round shape F-action 
accumulation in addition to its plasma membrane accumulation. (B) The 
accumulation of F-actin around granules immediately after degranulation. 
RBL-2H3 cells were co-transfected with the DsRed-fused signal peptide of 
-hexosaminidase and GFP-actin. After 24h, the cells were treated with 1 
M ionomycin (upper) or 50 ng/ml DNP-BSA (lower) and monitored using 
confocal microscopy. White arrows point to secreting granules.   
 
Figure S7. PKC-dependent actin polymerization during antigen-induced 
degranulation. 
Azelastine-trated (A) or PKC siRNA-transfected (B) RBL-2H3 cells were 
stimulated with 50 ng/ml DNP-BSA , and actin polymerization was monitored with 
FITC-phalloidin by FACS. The average of fluorescence of each FITC histograms in 
the three independent experiments are shown with SD. * show significant 
differences against control at 0 min with P<0.05, while # indicates significant 
differences between control (-AZ or -PKC siRNA) and test (+AZ or +PKC siRNA) 
with P <0.05. 
 
Figure S8. Protein View of Mascot Search Results of MBP-cofilin phosphorylated by 
PKCα. 
A candidate of phosphorylated peptide was detected by peptide mass fingerprinting 
using a peptide mass list from the ESI mass spectrum of tryptic digest of 
MBP-cofilin obtained from in vitro phosphorylation assay. The matched peptide list 
of Mascot search results was suggested that at least one Ser/Thr residue was 
phosphorylated in the peptide, VFNDMKVRKSSTPEEVKK (amino acids 405-422 of 
MBP-cofilin), corresponding to amino acids 14-31 of cofilin . Ion peak of 
triply-protonated peptide at m/z 740.05 was significantly observed on the ESI mass 
spectrum of tryptic digest of MBP-cofilin obtained from in vitro phosphorylation 
assay in the presence of ATP (Fig. 4A). This signal was not observed on the ESI 
mass spectrum of the product of the assay in the absence of ATP (Fig. 4B). The 
observed mass value 2218.15 Da of mono-protonated molecule (singly charged 
molecule) obtained from m/z value 740.05 expresses that experimental mass value 
of the molecule giving the ion at m/z 740.05 is 2217.1427 Da. This mass value is 
nearly identical with the calculated mass value 22.17.0864 Da of the peptide 
VFNDMKVRKSSTPEEVKK with one phosphorylated Ser/Thr and one oxidized Met 
with difference between 25 ppm. 
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